Home > Catalogues

Alpha-Tocopherol, Beta-Carotene Cancer Prevention [ATBC] Download as PDF

GENERAL INFORMATION

Name Alpha-Tocopherol, Beta-Carotene Cancer Prevention
Acronym ATBC
Last update 03/19/2009

Affiliation

Principal investigator

No information available

Contact

Demetrius Albanes
National Cancer Institute
Phone: 011-358-0-947-441
Email: daa@nih.govMail

Website

OBJECTIVES

To investigate whether daily supplementation with alpha-tocopherol, beta-carotene, or both would reduce the incidence of lung or other cancers among male smokers.

METHODS

Legend Yes No Unknown

General design

Study design Clinical / intervention trial
Type of participants Individuals, Random assignement of the participants to one of four groups that received for 5-8 years: 1) alpha-tocopherol (50 mg/day), 2) beta-carotene (20 mg/day), 3) both supplements or 4) placebo capsules.
Supplementary informations Random assignement of the participants to one of four groups that received for 5-8 years:
1) alpha-tocopherol (50 mg/day),
2) beta-carotene (20 mg/day),
3) both supplements or
4) placebo capsules.
Target or final number of participants 29133
Target or final number of DNA No information available

Participant selection / Characteristics of the population

Selection criteria

Yes Gender Men
Yes Age Minimun: 50 years    Maximun: 69 years
Yes Country of residence Finland
Yes Other criteria Men who smoked at least five cigarettes per day and reside in the southwestern Finland.

STATUS

Current status

Phase Start End
Preparation phase/Pilot 1984 1985
Recruitment / initial data collection 1985 1988
Follow-up of participants 1985 1993

Supplementary informations

Follow-up:
1) three annual visits,
2) at 3 years, food frequency questionnaire,
3) follow-up through Cancer Registry and governmental databases.
Several blood samples from each participant.

Current number of participants recruited 29133
Current number of collected DNA samples 29133

© 2005 Public Population Project in Genomics.
All rights reserved.
Information Usage